BRAINLIFE.ORG





Current Neuro-Oncology




Volume 26 Number 25
10 November 2024




Home > Publications > Current Neuro-Oncology > Volume 26, Year 2024 > Number 25, 10 November






*Chiche D, Taillandier L, Blonski M, Planel S, Obara T, Anxionnat R, Rech F.
DTI analysis of the peritumoral zone of diffuse low-grade gliomas in progressing patients.
World Neurosurg. 2024 Nov 1:S1878-8750(24)01811-4? doi: 10.1016/j.wneu.2024.10.111? PMID: 39489335. Observational study˰ ˍ




*Gao L, Yuan T, Liu Y, Yang X, Li Y, Quan G.
Prognostic nomogram model based on quantitative metrics of subregions surrounding residual cavity in glioblastoma patients.
J Cancer Res Clin Oncol. 2024 Nov 1;150(11):483. doi: 10.1007/s00432-024-06008-6. PMID: 39487262. Observational study. ˍ




Khalafallah AM, Shah KH, Knott MV, Berke CN, Shah AH, Komotar RJ, Ivan ME.
Evaluating laser interstitial thermal therapy for newly diagnosed, deep-seated, large-volume glioblastoma: survival and outcome analysis.
Neurosurg Focus. 2024 Nov 1;57(5):E3. doi: 10.3171/2024.8.FOCUS24457. PMID: 39486051. Observational study. ˍ




Mehta NH, Patel RV, Gupta S, Arora H, Nawabi NL, Karanth R, Sadler S, Medeiros L, Jha R, Chavarro VS, Bernstock JD, Smith TR, Arnaout O.
Cerebellopontine Angle Meningiomas: A Multi-Institutional Cohort Study.
Neurosurgery. 2024 Nov 1. doi: 10.1227/neu.0000000000003258. PMID: 39485023. Case report˰ ˍ




Peña Pino I, Bartek J, Ben-Haim S, Chen CC.
Patient-reported outcome and preference after craniotomy and laser interstitial thermal therapy ablation: a pilot study.
Neurosurg Focus. 2024 Nov 1;57(5):E7. doi: 10.3171/2024.8.FOCUS24442. PMID: 39486062. Observational study. ˍ




Wilhelmy B, Serra R, Chen C, Mishra M, Rodrigues D, Badjatia N, Motta M, Ksendzovsky A, Woodworth GF.
An analysis of functional outcomes following laser interstitial thermal therapy for recurrent high-grade glioma.
Neurosurg Focus. 2024 Nov 1;57(5):E4. doi: 10.3171/2024.8.FOCUS24460. PMID: 39486067. Observational study. ˍ




Basso J, Matos AM, Ghavami S, Fortuna A, Vitorino R, Vitorino C.
Are we better together? Addressing a combined treatment of pitavastatin and temozolomide for brain cancer.
Eur J Pharmacol. 2024 Nov 2;985:177087. doi: 10.1016/j.ejphar.2024.177087. PMID: 39491742. Laboratory investigation. ˍ




Fujimoto Y, Fujita Y, Tanaka K, Nagashima H, Yamanishi S, Ikeuchi Y, Iwahashi H, Sanada S, Muragaki Y, Sasayama T.
Clinical Benefits of Photodynamic Therapy Using Talaporfin Sodium in Patients With Isocitrate Dehydrogenase-Wildtype Diagnosed Glioblastoma: A Retrospective Study of 100 Cases.
Neurosurgery. 2024 Nov 4. doi: 10.1227/neu.0000000000003247. PMID: 39495040. Observational study˰ ˍ




*Hu X, Zhang G, Xie R, Wang Y, Zhu Y, Ding H.
Contrast-enhanced ultrasound can differentiate the level of glioma infiltration and correlate it with biological behavior: a study based on local pathology.
J Ultrasound. 2024 Nov 4. doi: 10.1007/s40477-024-00961-1. PMID: 39489864. Observational study˰ ˍ




Karschnia P, Young JS, Youssef GC, Dono A, Häni L, Sciortino T, Bruno F, Juenger ST, Teske N, Dietrich J, Weller M, Vogelbaum MA, van den Bent M, Beck J, Thon N, Gerritsen JKW, Hervey-Jumper S, Cahill DP, Chang SM, Rudà R, Bello L, Schnell O, Esquenazi Y, Ruge MI, Grau SJ, Huang RY, Wen PY, Berger MS, Molinaro AM, Tonn JC; RANO resect group.
Development and validation of a clinical risk model for postoperative outcome in newly diagnosed glioblastoma: a report of the RANO resect group.
Neuro Oncol. 2024 Nov 4:noae231. doi: 10.1093/neuonc/noae231. PMID: 39492786. Observational study. ˍ




Wang M, Liu G, Liang Y, Lyu Z, Tang Z, Tan F, Wei R.
Clinical results of helical tomotherapy for high-grade gliomas.
Int J Radiat Biol. 2024 Nov 4:1-13. doi: 10.1080/09553002.2024.2418500. PMID: 39495095. Observational study˰ ˍ




Dinapoli L, Caliandro M, Chiesa S, Marconi E, Capocchiano ND, Mazzarella C, Bartoli FB, Bracci S, Balducci M, Chieffo DPR, Fiorentino A, Valentini V, Tagliaferri L, Gambacorta MA, Dinapoli N.
Resilience and spiritual well-being as resources for coping with radiotherapy and surviving in patients with glioblastoma.
Palliat Support Care. 2024 Nov 5:1-9. doi: 10.1017/S1478951524001111. PMID: 39497355. Observational study. ˍ




*Knight TE, Broglie L, Sharma A, Qayed M, Yanik GA.
Why are Higher CD34+ Cell Doses Associated with Improved Outcomes among Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplant for Central Nervous System Tumors - But Not for High-Risk Neuroblastoma?
Pediatr Hematol Oncol. 2024 Nov 5:1-5. doi: 10.1080/08880018.2024.2420924. PMID: 39501613. Observational study˰ ˍ




Tobochnik S, Regan MS, Dorotan MKC, Reich D, Lapinskas E, Hossain MA, Stopka S, Meredith DM, Santagata S, Murphy MM, Arnaout O, Bi WL, Chiocca EA, Golby AJ, Mooney MA, Smith TR, Ligon KL, Wen PY, Agar NYR, Lee JW.
Pilot Trial of Perampanel on Peritumoral Hyperexcitability in Newly Diagnosed High-grade Glioma.
Clin Cancer Res. 2024 Nov 5:OF1-OF9. doi: 10.1158/1078-0432.CCR-24-1849. PMID: 39499201. Interventional study. ˍ
REFERS TO:
Tobochnik S, Regan MS, Dorotan MKC, Reich D, Lapinskas E, Hossain MA, Stopka S, Santagata S, Murphy MM, Arnaout O, Bi WL, Antonio Chiocca E, Golby AJ, Mooney MA, Smith TR, Ligon KL, Wen PY, Agar NYR, Lee JW.
Pilot trial of perampanel on peritumoral hyperexcitability and clinical outcomes in newly diagnosed high-grade glioma.
medRxiv [Preprint]. 2024 Apr 18:2024.04.11.24305666. doi: 10.1101/2024.04.11.24305666. PMID: 38645003. Interventional study. ˍ




Kan A, Marokakis S, Ward JH, Kim S, Gabriel M, Durkan AM.
Long-term renal outcomes of children with cancers treated with platinum-based chemotherapy: A retrospective chart analysis.
Pediatr Blood Cancer. 2024 Nov 6:e31404. doi: 10.1002/pbc.31404. PMID: 39503057. Observational study˰ ˍ




Landry AP, Wang JZ, Patil V, Gui C, Yasin M, Patel Z, Yakubov R, Kaloti R, Habibi P, Wilson M, Ajisebutu A, Ellenbogen Y, Wei Q, Singh O, Sosa J, Mansouri S, Wilson C, Cohen-Gadol AA, Virtanen P, Burket N, Blackwell M, Koenig J, Alfonso A, Davis J, Zaazoue MA, Tabatabai G, Tatagiba M, Behling F, Barnholtz-Sloan JS, Sloan AE, Chotai S, Chambless LB, Mansouri A, Ehret F, Capper D, Tsang DS, Aldape K, Gao A; International Consortium on Meningiomas (ICOM); Nassiri F, Zadeh G.
Validation and next-generation update of a DNA methylation-based recurrence predictor for meningioma: a multicenter prospective study. Neuro Oncol. 2024 Nov 6:noae236. doi: 10.1093/neuonc/noae236. PMID: 39503370. Observational study. ˍ